{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:45Z","timestamp":1787020785046,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02612-7","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:05:28Z","timestamp":1737360328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of human leukocyte antigen in HTLV-1 infection and progression to ATLL and HAM\/TSP: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Shayan","family":"Mardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rashidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Bastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazale","family":"Molaverdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-2252","authenticated-orcid":false,"given":"Sayed-Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"6","key":"2612_CR1","first-page":"485","volume":"32","author":"E Eusebio-Ponce","year":"2019","unstructured":"Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ. HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter. 2019;32(6):485\u201396.","journal-title":"Rev Esp Quimioter."},{"key":"2612_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.","journal-title":"Front Microbiol"},{"issue":"5","key":"2612_CR3","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/pathogens12050735","volume":"12","author":"S Mohanty","year":"2023","unstructured":"Mohanty S, Harhaj EW. Mechanisms of innate immune sensing of HTLV-1 and viral immune evasion. Pathogens. 2023;12(5):735.","journal-title":"Pathogens"},{"issue":"11","key":"2612_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ph16111546","volume":"16","author":"MCMD Silva","year":"2023","unstructured":"Silva MCMD, Pereira RSB, Araujo ACA, Filho EGDS, Dias ADL, Cavalcante KS, Sousa MSD. New perspectives about drug candidates targeting HTLV-1 and related diseases. Pharmaceuticals. 2023;16(11):1546.","journal-title":"Pharmaceuticals."},{"issue":"1","key":"2612_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CR Bangham","year":"2018","unstructured":"Bangham CR. Human T cell leukemia virus type 1: persistence and pathogenesis. Annual Rev Immunol. 2018;36(1):43\u201371. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053222","journal-title":"Annual Rev Immunol"},{"key":"2612_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","volume":"3","author":"M Iwanaga","year":"2012","unstructured":"Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.","journal-title":"Front Microbiol"},{"key":"2612_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3389\/fmicb.2019.01101","volume":"10","author":"M Saito","year":"2019","unstructured":"Saito M. Association between HTLV-1 genotypes and risk of HAM\/TSP. Front Microbiol. 2019;10:1101.","journal-title":"Front Microbiol"},{"issue":"11","key":"2612_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/v11110974","volume":"11","author":"ACR Vallinoto","year":"2019","unstructured":"Vallinoto ACR, Cayres-Vallinoto I, Freitas Queiroz MA, Ishak MOG, Ishak R. Influence of immunogenetic biomarkers in the clinical outcome of HTLV-1 infected persons. Viruses. 2019;11(11):974.","journal-title":"Viruses."},{"issue":"12","key":"2612_CR9","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1097\/QAD.0b013e32833c3219","volume":"24","author":"X Gao","year":"2010","unstructured":"Gao X, O\u2019Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ, et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS. 2010;24(12):1835\u201340.","journal-title":"AIDS"},{"issue":"3","key":"2612_CR10","doi-asserted-by":"publisher","first-page":"e0265348","DOI":"10.1371\/journal.pone.0265348","volume":"17","author":"C Muccini","year":"2022","unstructured":"Muccini C, Guffanti M, Spagnuolo V, Cernuschi M, Galli L, Bigoloni A, et al. Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection. PLoS ONE. 2022;17(3):e0265348.","journal-title":"PLoS ONE"},{"issue":"1","key":"2612_CR11","doi-asserted-by":"publisher","first-page":"e2378","DOI":"10.1002\/rmv.2378","volume":"33","author":"Z Dobrijevi\u0107","year":"2023","unstructured":"Dobrijevi\u0107 Z, Gligorijevi\u0107 N, \u0160underi\u0107 M, Penezi\u0107 A, Milju\u0161 G, Tomi\u0107 S, Nedi\u0107 O. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: a systematic review and meta-analysis. Rev Med Virol. 2023;33(1):e2378.","journal-title":"Rev Med Virol"},{"issue":"4","key":"2612_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01466.x","volume":"75","author":"SG Marsh","year":"2010","unstructured":"Marsh SG, Albert E, Bodmer W, Bontrop R, Dupont B, Erlich H, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291.","journal-title":"Tissue Antigens"},{"key":"2612_CR13","volume-title":"Categorical data analysis","author":"A Agresti","year":"2012","unstructured":"Agresti A. Categorical data analysis. Wiley; 2012."},{"issue":"10","key":"2612_CR14","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1099\/jgv.0.000559","volume":"97","author":"DC Ciliao Alves","year":"2016","unstructured":"Ciliao Alves DC, Haddad R, Rocha-J\u00fanior MC, de Deus Wagatsuma VM, Martelli-Palomino G, Marques AA, et al. HLA-G 3\u2032-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy\/tropical spastic paraparesis development. J Gen Virol. 2016;97(10):2742\u201352.","journal-title":"J Gen Virol"},{"key":"2612_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-008-0096-z","volume":"198","author":"B Catalan-Soares","year":"2009","unstructured":"Catalan-Soares B, Carneiro-Proietti ABF, Da Fonseca F, Correa-Oliveira R, Peralva-Lima D, Portela R, et al. HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med Microbiol Immunol. 2009;198:1\u20133.","journal-title":"Med Microbiol Immunol"},{"issue":"11","key":"2612_CR16","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.1016\/j.ijid.2010.05.020","volume":"14","author":"R Deschamps","year":"2010","unstructured":"Deschamps R, B\u00e9ra O, Belrose G, Lezin A, Bellance R, Signate A, et al. Absence of consistent association between human leukocyte antigen-I and-II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population. Int J Infect Dis. 2010;14(11):e986\u201390.","journal-title":"Int J Infect Dis"},{"key":"2612_CR17","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1099\/jgv.0.000559","volume":"97","author":"DCC Alves","year":"2016","unstructured":"Alves DCC, Haddad R, Rocha MC, Wagatsuma VMD, Martelli-Palomino G, Marques AA, et al. HLA-G3\u2019-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy\/tropical spastic paraparesis development. J Gen Virol. 2016;97:2742\u201352.","journal-title":"J Gen Virol"},{"issue":"11","key":"2612_CR18","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.1016\/j.ijid.2010.05.020","volume":"14","author":"R Deschamps","year":"2010","unstructured":"Deschamps R, B\u00e9ra O, Belrose G, Lezin A, Bellance R, Signate A, et al. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population. Int J Infect Dis. 2010;14(11):e986\u201390.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"2612_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","volume":"177","author":"I Elovaara","year":"1993","unstructured":"Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;177(6):1567\u201373.","journal-title":"J Exp Med"},{"issue":"5","key":"2612_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1086\/315897","volume":"182","author":"Y Furukawa","year":"2000","unstructured":"Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the <i>tax<\/i> gene and their association with different risks for HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis. 2000;182(5):1343\u20139.","journal-title":"J Infect Dis"},{"issue":"5","key":"2612_CR21","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/ijc.22767","volume":"121","author":"JJ Goedert","year":"2007","unstructured":"Goedert JJ, Li HC, Gao XJ, Chatterjee N, Sonoda S, Biggar RJ, et al. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer. 2007;121(5):1092\u20137.","journal-title":"Int J Cancer"},{"issue":"4","key":"2612_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ijc.2910410406","volume":"41","author":"Group TaBcMS","year":"1988","unstructured":"Group TaBcMS. The third nation-wide study on adult T-cell leukemia\/lymphoma (ATL) in Japan: characteristic patterns of hla antigen and HTLV-I infection in ATL patients and their relatives. Int J Cancer. 1988;41(4):505\u201312.","journal-title":"Int J Cancer"},{"issue":"3","key":"2612_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/aid.2010.0165","volume":"27","author":"R Haddad","year":"2011","unstructured":"Haddad R, Cili\u00e3o Alves DC, Rocha-Junior MC, Azevedo R, Pombo-de-Oliveira MS, Takayanagui OM, et al. HLA-G 14-bp insertion\/deletion polymorphism is a risk factor for HTLV-1 infection. AIDS Res Hum Retroviruses. 2011;27(3):283\u20138.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"2612_CR24","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","volume":"165","author":"KJ Jeffery","year":"2000","unstructured":"Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000;165(12):7278\u201384.","journal-title":"J Immunol"},{"issue":"7","key":"2612_CR25","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci. 1999;96(7):3848\u201353.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"2612_CR26","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","volume":"177","author":"T Kozako","year":"2006","unstructured":"Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, Hamada H, et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol. 2006;177(8):5718\u201326.","journal-title":"J Immunol"},{"issue":"5","key":"2612_CR27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1399-0039.1998.tb03071.x","volume":"52","author":"H Lou","year":"1998","unstructured":"Lou H, Li HC, Kuwayama M, Yashiki S, Fujiyoshi T, Suehara M, et al. HLA class I and class II of the Nivkhi, an indigenous population carrying HTLV-I in Sakhalin, Far Eastern Russia. Tissue Antigens. 1998;52(5):444\u201351.","journal-title":"Tissue Antigens"},{"issue":"8","key":"2612_CR28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jnci\/90.8.617","volume":"90","author":"A Manns","year":"1998","unstructured":"Manns A, Nam J-M, Blattner W, Hanchard B, Morgan OSC, Wilks R, et al. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia\/lymphoma in a Black population. JNCI J Natl Cancer Inst. 1998;90(8):617\u201322.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"12","key":"2612_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0198-8859(00)00182-8","volume":"61","author":"M Nishimura","year":"2000","unstructured":"Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, et al. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-\u03b1, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol. 2000;61(12):1262\u20139.","journal-title":"Hum Immunol"},{"issue":"11","key":"2612_CR30","doi-asserted-by":"publisher","first-page":"e2004199118","DOI":"10.1073\/pnas.2004199118","volume":"118","author":"M Penova","year":"2021","unstructured":"Penova M, Kawaguchi S, Yasunaga JI, Kawaguchi T, Sato T, Takahashi M, et al. Genome wide association study of HTLV-1-associated myelopathy\/tropical spastic paraparesis in the Japanese population. Proc Natl Acad Sci USA. 2021;118(11):e2004199118.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2612_CR31","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.humimm.2004.05.006","volume":"65","author":"H Rafatpanah","year":"2004","unstructured":"Rafatpanah H, Pravica V, Farid R, Abbaszadegan MR, Tabatabaei A, Goharjoo A, et al. Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from Northeast Iran (Mash-had). Hum Immunol. 2004;65(8):839\u201346.","journal-title":"Hum Immunol"},{"issue":"1","key":"2612_CR32","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1038\/s41598-023-34757-w","volume":"13","author":"D Schor","year":"2023","unstructured":"Schor D, Porto LC, Roma EH, Castro-Alves J, Villela AP, Ara\u00fajo AQC, Gl\u00f3ria Bonecini-Almeida M. Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) population. Sci Rep. 2023;13(1):7659.","journal-title":"Sci Rep"},{"issue":"2","key":"2612_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1399-0039.1996.tb02618.x","volume":"48","author":"B Shohat","year":"1996","unstructured":"Shohat B, Achiron A, Narinski R, Kochba I, Sidi Y, Sonada S, et al. Possible HLA association with susceptibility to HTLV-1 tropical spastic paraparesis in Israel in Iranian Jews as compared to HTLV 1-associated myelopathy in Japan. Tissue Antigens. 1996;48(2):136\u20138.","journal-title":"Tissue Antigens"},{"issue":"10","key":"2612_CR34","first-page":"798","volume":"17","author":"AR Tafreshian","year":"2014","unstructured":"Tafreshian AR, Etemadi M, Farid-Hosseini R, Salhi M, Afshari JT. Association between HLA-DQB1 alleles and HAM\/TSP patients in Khorasan Province. Iran J Basic Med Sci. 2014;17(10):798\u2013801.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"2612_CR35","first-page":"264","volume":"16","author":"M Taghaddosi","year":"2013","unstructured":"Taghaddosi M, Rahim Rezaee SA, Rafatpanah H, Rajaei T, Farid Hosseini R, Narges V. Association between HLA class I alleles and proviral load in HTLV-I associated myelopathy\/tropical spastic paraperesis (HAM\/TSP) patients in Iranian population. Iran J Basic Med Sci. 2013;16(3):264\u20137.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"2612_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jmv.21675","volume":"82","author":"M Talledo","year":"2010","unstructured":"Talledo M, L\u00f3pez G, Huyghe JR, Verdonck K, Adaui V, Gonz\u00e1lez E, et al. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy\/tropical spastic paraparesis in peruvian HTLV-1-infected patients. J Med Virol. 2010;82(3):460\u20136.","journal-title":"J Med Virol"},{"key":"2612_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2016.11.009","volume":"228","author":"H Tarokhian","year":"2017","unstructured":"Tarokhian H, Taghadosi M, Rafatpanah H, Rajaei T, Azarpazhooh MR, Valizadeh N, Rezaee SAR. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis. Virus Res. 2017;228:1\u20136.","journal-title":"Virus Res"},{"issue":"10","key":"2612_CR38","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1007\/s00415-013-7014-z","volume":"260","author":"A Trevi\u00f1o","year":"2013","unstructured":"Trevi\u00f1o A, Vicario JL, Lopez M, Parra P, Benito R, Ortiz De Lejarazu R, et al. Association between HLA alleles and HAM\/TSP in individuals infected with HTLV-1. J Neurol. 2013;260(10):2551\u20135.","journal-title":"J Neurol."},{"issue":"7","key":"2612_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1086\/342953","volume":"186","author":"AM Vine","year":"2002","unstructured":"Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis. 2002;186(7):932\u20139.","journal-title":"J Infect Dis"},{"issue":"11","key":"2612_CR40","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/088922201300343735","volume":"17","author":"S Yashiki","year":"2001","unstructured":"Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y, et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses. 2001;17(11):1047\u201361.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2612_CR41","doi-asserted-by":"publisher","first-page":"622176","DOI":"10.3389\/fimmu.2021.622176","volume":"12","author":"I Fricke-Galindo","year":"2021","unstructured":"Fricke-Galindo I, Falf\u00e1n-Valencia R. Genetics insight for COVID-19 susceptibility and severity: a review. Front Immunol. 2021;12:622176.","journal-title":"Front Immunol"},{"key":"2612_CR42","doi-asserted-by":"crossref","unstructured":"Yengo CK, Torimiro J, Kowo M, Lebon PA, Tiedeu BA, Luma H, et al. Variation of HLA class I (-A and-C) genes in individuals infected with hepatitis B or hepatitis C virus in Cameroon. Heliyon. 2020;6(10).","DOI":"10.1016\/j.heliyon.2020.e05232"},{"issue":"2","key":"2612_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/v8020038","volume":"8","author":"T Assone","year":"2016","unstructured":"Assone T, Paiva A, Fonseca LAM, Casseb J. Genetic markers of the host in persons living with HTLV-1, HIV and HCV infections. Viruses. 2016;8(2):38.","journal-title":"Viruses"},{"issue":"2","key":"2612_CR44","first-page":"94","volume":"4","author":"H Rafatpanah","year":"2007","unstructured":"Rafatpanah H, Pravica V, FaridHosseini R, Tabatabaei A, Ollier W, Poulton K, et al. Association between HLA-DRB1* 01 and HLA-Cw* 08 and outcome following HTLV-I infection. Iran J Immunol. 2007;4(2):94\u2013100.","journal-title":"Iran J Immunol"},{"issue":"5","key":"2612_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1399-0039.2008.01031.x","volume":"71","author":"Y Matsumura","year":"2008","unstructured":"Matsumura Y, Kinouchi Y, Nomura E, Negoro K, Kakuta Y, Endo K, et al. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis. Tissue Antigens. 2008;71(5):447\u201352.","journal-title":"Tissue Antigens"},{"issue":"3","key":"2612_CR46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2230.2009.03506.x","volume":"35","author":"J Brown","year":"2010","unstructured":"Brown J, Ollier W, Arscott G, Bayat A. Association of HLA-DRB1* and keloid disease in an Afro-Caribbean population. Clin Exp Dermatol. 2010;35(3):305\u201310.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"2612_CR47","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.humimm.2013.12.009","volume":"75","author":"Z Andric","year":"2014","unstructured":"Andric Z, Popadic D, Jovanovic B, Jaglicic I, Bojic S, Simonovic R. HLA-A,-B,-C,-DRB1 and-DQB1 allele and haplotype frequencies in the Serbian population. Hum Immunol. 2014;75(3):218\u201326.","journal-title":"Hum Immunol"},{"issue":"1","key":"2612_CR48","first-page":"4","volume":"1","author":"Z Grubic","year":"2018","unstructured":"Grubic Z. Human leukocyte antigen polymorphism in search for a matched unrelated donor in haematopoietic stem cell transplantation. Mol Exp Biol Med. 2018;1(1):4\u201312.","journal-title":"Mol Exp Biol Med"},{"issue":"4","key":"2612_CR49","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/jdi.12462","volume":"7","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zhao L, Wang B, Gao J, Wang L, Li L, et al. HLA-A* 33-DR 3 and A* 33-DR 9 haplotypes enhance the risk of type 1 diabetes in Han Chinese. J Diabetes Investig. 2016;7(4):514\u201321.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"2612_CR50","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2005.09.006","volume":"118","author":"MM Vacek","year":"2006","unstructured":"Vacek MM, Sch\u00e4ffer AA, Davis J, Fischer RE, Dale JK, Adams S, et al. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia). Clin Immunol. 2006;118(1):59\u201365.","journal-title":"Clin Immunol"},{"issue":"7","key":"2612_CR51","doi-asserted-by":"publisher","first-page":"e39986","DOI":"10.1371\/journal.pone.0039986","volume":"7","author":"X Huang","year":"2012","unstructured":"Huang X, Kushekhar K, Nolte I, Kooistra W, Visser L, Bouwman I, et al. HLA associations in classical Hodgkin lymphoma: EBV status matters. PLoS ONE. 2012;7(7):e39986.","journal-title":"PLoS ONE"},{"key":"2612_CR52","doi-asserted-by":"crossref","unstructured":"Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http:\/\/www.allelefrequencies.net. Tissue Antigens. 2003;61(5):403\u20137.","DOI":"10.1034\/j.1399-0039.2003.00062.x"},{"issue":"4","key":"2612_CR53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/1523-1747.ep12484029","volume":"97","author":"I Khalil","year":"1991","unstructured":"Khalil I, Lepage V, Douay C, Morin L, Al-Daccak R, Wallach D, et al. HLA DQB1* 0301 allele is involved in the susceptibility to erythema multiforme. J Investig Dermatol. 1991;97(4):697\u2013700.","journal-title":"J Investig Dermatol"},{"issue":"8","key":"2612_CR54","first-page":"1266","volume":"124","author":"CA Fernandez","year":"2014","unstructured":"Fernandez CA, Smith C, Yang W, Dat\u00e9 M, Bashford D, Larsen E, et al. HLA-DRB1* 07: 01 is associated with a higher risk of asparaginase allergies. Blood J Am Soc Hematol. 2014;124(8):1266\u201376.","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"2612_CR55","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1046\/j.1365-2133.1998.02552.x","volume":"139","author":"SH Jee","year":"1998","unstructured":"Jee SH, Tsai TF, Tsai WL, Liaw SH, Chang CH, Hu CY. HLA-DRB1* 0701 and DRB1* 1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population. Br J Dermatol. 1998;139(6):978\u201383.","journal-title":"Br J Dermatol"},{"key":"2612_CR56","unstructured":"Ya-qin H, Lin X, Zhu A, Lin-lin W, Rong X. Characteristics of neuropsychological, sleep structure and distribution of HLA-DQB1 genotype of narcolepsy type 1. Chin J Contemp Neurol Neurosurg. 2023;23(8)."},{"issue":"13","key":"2612_CR57","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.3390\/ijms25136858","volume":"25","author":"M Tanaka","year":"2024","unstructured":"Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E, et al. HLA-A* 24 increases the risk of HTLV-1-associated myelopathy despite reducing HTLV-1 proviral load. Int J Mol Sci. 2024;25(13):6858.","journal-title":"Int J Mol Sci"},{"key":"2612_CR58","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.bjid.2021.101594","volume":"25","author":"C Brites","year":"2021","unstructured":"Brites C, Grassi MF, Quaresma JAS, Ishak R, Vallinoto ACR. Pathogenesis of HTLV-1 infection and progression biomarkers: an overview. Braz J Infect Dis. 2021;25:101594.","journal-title":"Braz J Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T08:07:33Z","timestamp":1737360453000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02612-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by ethics committee of Alborz University of Medical Sciences, Alborz, Iran\u00a0(Ethics Code:\u00a0IR.ABZUMS.REC.1402.197).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}